Start-Up Previews (07/2008)
A preview of the emerging health care companies profiled in the current, all-profiles issue of Start-Up. This month's profile groups are "Glioblastoma Start-Ups Get Specific," "Glaucoma Start-Ups Reach Critical Mass," and "ALS on the Cusp." Plus these Start-Ups Across Health Care: EarlySense, NeoChord, and Pantec Biosolutions.
You may also be interested in...
Israeli start-up EarlySense is a new entrant in the patient supervision and monitoring market. Its EverOn supervision system allows patients to be easily and continuously supervised without any physical contact or connections.
In the field of glaucoma, there are a lot of unknowns because it hasn't previously been feasible to continuously monitor intraocular pressure. Sensimed was formed to do just that. The young company is developing a sensor that would provide 24-hours worth of intraocular pressure data as an alternative to the point-by-point measurement systems available today. The company likens its device to the Holter monitor in cardiovascular disease-a device that can yield a comprehensive set of diagnostic data as a patient goes about his or her daily life.
NeoChord wants to enable less invasive mitral valve repair with the NeoChord DS1000 is a tool for implanting artificial chordae tendineae made of suturing material while the heart is still beating.